Dext Capital closed Dext ABS 2025-2, its sixth asset-backed securitization. The transaction drew orders from 29 unique investors across six classes of investment-grade bonds, rated by Moody’s and S&P. The proceeds from this trade will be used to fund Dext’s ongoing growth initiatives within the essential-use healthcare and technology space.
“We’re thrilled to see this level of market engagement on Dext 2025-2 with strong oversubscription across the stack. This is a success story for the whole Dext team, all 150 of us,” Conrad Nilsen, senior vice president of finance for Dext Capital, said. “This group’s perseverance, innovation and intuition keep our origination pipeline and portfolio performance healthy, even in choppy markets. That’s a real differentiator. I look forward to building on this momentum to further support our vendor partners and customers in 2026.”
Truist Securities acted as sole structuring agent, with BofA Securities and Deutsche Bank Securities as lead bookrunners, and Regions Securities serving as co-manager.
